• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌的诊断时间:一项队列研究。

Time to diagnosis in esophageal cancer: a cohort study.

机构信息

a Surgical Oncology Unit , Veneto Institute of Oncology IOV IRCCS , Padova , Italy.

b Clinica Chirurgica 3, Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche DiSCOG , Azienda Ospedaliera-Università di Padova , Padova , Italy.

出版信息

Acta Oncol. 2018 Sep;57(9):1179-1184. doi: 10.1080/0284186X.2018.1457224. Epub 2018 Mar 30.

DOI:10.1080/0284186X.2018.1457224
PMID:29600882
Abstract

BACKGROUND

The association between shorter time to diagnosis and favorable outcome is still unproven in esophageal cancer. This study aims to evaluate the effect of time to diagnosis on patient prognosis.

MATERIAL AND METHODS

Retrospective cohort study of all 3613 symptomatic patients referred for esophageal cancer to our center from 1980 to 2011. Time to diagnosis was calculated as the number of days from first symptom onset to the diagnosis of esophageal cancer. The main outcome measures were: resectability and severe malnutrition at diagnosis; postoperative morbidity, mortality and survival.

RESULTS

Longer time to diagnosis was significantly associated with severe malnutrition at diagnosis (odds ratio (OR): 1.003, 95% confidence interval (C.I.).: 1.001-1.006) but not with resectability (OR: 0.997, 95% C.I.: 0.994-1.001). Longer time to diagnosis was not associated with postoperative morbidity (OR: 1.000, 95% C.I.: 0.998-1.003), postoperative mortality (OR: 1.002, 95% C.I.: 0.998-1.006), five-year overall survival (hazard ratio (HR): 0.999, 95% C.I.: 0.997-1.001) or five-year disease free survival (HR: 0.999, 95% C.I.: 0.998-1.001).

CONCLUSION

Longer time to diagnosis did not affect resectability, postoperative morbidity or survival. Further campaigns to raise awareness of cancer among population and primary health care providers may have limited effect on clinical outcome.

摘要

背景

在食管癌中,较短的诊断时间与较好的预后之间的关联尚未得到证实。本研究旨在评估诊断时间对患者预后的影响。

材料与方法

回顾性队列研究,纳入了 1980 年至 2011 年期间因食管癌就诊于我们中心的所有 3613 例有症状患者。诊断时间的计算方法为从首次症状出现到确诊食管癌的天数。主要结局指标为:诊断时的可切除性和严重营养不良;术后发病率、死亡率和生存率。

结果

较长的诊断时间与诊断时的严重营养不良显著相关(优势比(OR):1.003,95%置信区间(CI):1.001-1.006),但与可切除性无关(OR:0.997,95%CI:0.994-1.001)。诊断时间延长与术后发病率(OR:1.000,95%CI:0.998-1.003)、术后死亡率(OR:1.002,95%CI:0.998-1.006)、五年总生存率(风险比(HR):0.999,95%CI:0.997-1.001)或五年无病生存率(HR:0.999,95%CI:0.998-1.001)无关。

结论

诊断时间延长并不影响可切除性、术后发病率或生存率。提高公众和初级保健提供者对癌症的认识的进一步宣传活动可能对临床结果的影响有限。

相似文献

1
Time to diagnosis in esophageal cancer: a cohort study.食管癌的诊断时间:一项队列研究。
Acta Oncol. 2018 Sep;57(9):1179-1184. doi: 10.1080/0284186X.2018.1457224. Epub 2018 Mar 30.
2
A population-based, retrospective, cohort study of esophageal cancer missed at endoscopy.基于人群的、回顾性的、内镜检查漏诊食管癌的队列研究。
Endoscopy. 2014 Jul;46(7):553-60. doi: 10.1055/s-0034-1365646. Epub 2014 Jun 27.
3
Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden.食管癌的临床表现、治疗和结局因医院的安全网负担而异。
Ann Thorac Surg. 2019 May;107(5):1472-1479. doi: 10.1016/j.athoracsur.2018.11.065. Epub 2018 Dec 31.
4
Esophageal cancer. Clinical and pathologic features.食管癌。临床与病理特征。
Radiol Clin North Am. 1997 Mar;35(2):243-63.
5
Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.美国退伍军人事务部加勒比海医疗系统的食管癌亚型与生存率:十年经验
Bol Asoc Med P R. 2009 Jul-Sep;101(3):14-7.
6
Oesophageal cancer in northern areas of Pakistan.巴基斯坦北部地区的食管癌
J Ayub Med Coll Abbottabad. 2009 Apr-Jun;21(2):148-50.
7
Changing trends in esophageal cancer: a 15-year experience in a single center.食管癌的变化趋势:单中心15年经验
Am J Gastroenterol. 1998 May;93(5):702-5. doi: 10.1111/j.1572-0241.1998.209_a.x.
8
[Does the time interval between diagnosis and treatment influence survival of patients with resectable esophageal cancer?].[诊断与治疗之间的时间间隔是否会影响可切除食管癌患者的生存率?]
Chirurg. 2016 Jun;87(6):535-6. doi: 10.1007/s00104-016-0211-4.
9
Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site.婚姻状况、教育程度和收入与组织学类型和部位相关的食管癌和胃癌风险的关系。
Cancer. 2016 Jan 15;122(2):207-12. doi: 10.1002/cncr.29731. Epub 2015 Oct 8.
10
Carcinoma of the esophagus in Tamil Nadu (South India): 16-year trends from a tertiary center.印度南部泰米尔纳德邦的食管癌:来自三级医疗中心的16年趋势
J Gastrointestin Liver Dis. 2007 Sep;16(3):245-9.

引用本文的文献

1
Association Between Pre-Diagnostic Delay and Survival Among Patients With Esophageal and Gastric Cancer Treated With Curative Intent During the COVID19 Pandemic.COVID-19大流行期间接受根治性治疗的食管癌和胃癌患者的诊断前延迟与生存之间的关联
Cancer Med. 2025 May;14(9):e70939. doi: 10.1002/cam4.70939.
2
Oesophageal cancer awareness and anticipated time to help-seeking: results from a population-based survey.食管癌认知和预期寻求帮助时间:基于人群的调查结果。
Br J Cancer. 2024 May;130(11):1795-1802. doi: 10.1038/s41416-024-02663-1. Epub 2024 Mar 30.
3
The Swedish Standardized Course of Care-Diagnostic Efficacy in Esophageal and Gastric Cancer.
瑞典食管癌和胃癌标准化护理疗程 - 诊断效能
Diagnostics (Basel). 2023 Dec 1;13(23):3577. doi: 10.3390/diagnostics13233577.
4
Influence of a patient navigation program on timeliness of care in patients with esophageal cancer.患者导航计划对食管癌患者护理及时性的影响。
Cancer Med. 2023 May;12(10):11907-11914. doi: 10.1002/cam4.5882. Epub 2023 Apr 19.
5
Palliative radiotherapy and quality of life in patients with locally advanced thoracic esophageal cancer: a single centre experience from Central India.局部晚期胸段食管癌患者的姑息性放疗与生活质量:来自印度中部的单中心经验
Rep Pract Oncol Radiother. 2022 Mar 22;27(1):104-112. doi: 10.5603/RPOR.a2021.0136. eCollection 2022.
6
Variation in Diagnosis, Treatment, and Outcome of Esophageal Cancer in a Regionalized Care System in Ontario, Canada.加拿大安大略省区域性照护体系中食管癌的诊断、治疗和结局的差异。
JAMA Netw Open. 2021 Sep 1;4(9):e2126090. doi: 10.1001/jamanetworkopen.2021.26090.
7
Understanding health-seeking and adherence to treatment by patients with esophageal cancer at the Uganda cancer Institute: a qualitative study.乌干达癌症研究所食管癌患者的就医行为及治疗依从性研究:一项定性研究
BMC Health Serv Res. 2021 Feb 18;21(1):159. doi: 10.1186/s12913-021-06163-3.
8
Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement?荷兰有症状的胃癌和食管癌的诊断时间:有哪些改进的空间?
United European Gastroenterol J. 2020 Jun;8(5):607-620. doi: 10.1177/2050640620917804. Epub 2020 Apr 6.
9
PBF, a Proto-oncogene in Esophageal Carcinoma.PBF,一种食管癌中的原癌基因。
Open Med (Wars). 2019 Oct 13;14:748-756. doi: 10.1515/med-2019-0086. eCollection 2019.